Metastases from Neuroendocrine Carcinoma: Value of Diffusion-Weighted MR Imaging Compared to PET-CT
Bernhard Klumpp, M.D.; Philip Aschoff, M.D.; Mehmet Oeksuez, M.D.; Christiane Pfannenberg, M.D.; Heinz-Peter Schlemmer, M.D.
University of Tuebingen, Tuebingen, Germany | 11.03.2010
At the European Congress of Radiology (ECR) in Vienna, diagnostic performance of diffusion-weighted imaging (DWI) gained special attention. DWI compared to PET/CT was in the focus of a variety of scientific presentations. While the exact future role of this imaging technique is still topic of scientific debate, its clinical value in a variety of indications is unquestionable. In their case report, Klumpp et al. from the University Hospital of Tuebingen (Germany) demonstrate how DWI is used to enhance the diagnoses of liver metastases in a case of a neuroendocrine tumor compared to conventional MRI and PET/CT examinations.
The information presented is for illustration only and is not intended to be relied upon by the reader for instruction as to the practice of medicine. Any health care practitioner reading this information is reminded that they must use their own learning, training and expertise in dealing with their individual patients. This material does not substitute for that duty and is not intended by Siemens Healthcare to be used for any purpose in that regard.
The drugs and doses mentioned herein are consistent with the approval labelling for uses and/or indications of the drug. The treating physician bears the sole responsibility for the diagnosis and treatment of patients, including drugs and doses prescribed in connection with such use. The Operating Instructions must always be strictly followed when operating the system. The source for the technical data is the corresponding data sheets. Results may vary.